Acquisition Target Potential upsell opportunities with Leidos-era relationships and legacy clients from IMX’s acquisition history, leveraging a shared background in independent medical evaluations and risk assessment to cross-sell enhanced review services and expanded case management.

Data Security Address data breach exposure in 2023 as a conversation starter for offering enhanced data protection, compliance assessments, and secure information handling solutions to clients concerned about PHI security and regulatory risk.

Network Reach Capitalize on IMX’s extensive national provider network to pitch scalable, multi-state independent medical opinions, functional capacity evaluations, and case management services to national insurers seeking centralized vendors.

Growth Potential Explore expansion opportunities with large insurance players and third-party administrators by highlighting URAC certification status, objective medical opinions grounded in literature, and a proven track record since 1995 to differentiate from competitors.

Tech Enablement Leverage IMX’s tech stack familiarity (REST, Confluence, WordPress, analytics/ERP tools) to propose integrated case dashboards, seamless data exchange, and reporting enhancements that improve efficiency for insurer clients and reduce cycle times.